coyatherapeutics.comHouston biotech company developing multiple Treg-based therapies
coyatherapeutics.com Profile
coyatherapeutics.com is a domain
that was created on 2020-10-22,making it 4 years ago.
It has several subdomains, such as ir.coyatherapeutics.com , among others.
Description：Houston-based clinical-stage company that develops multiple Treg-modulating therapies for neurodegenerative, autoimmune, and metabolic...
Discover coyatherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
coyatherapeutics.com Information
| HomePage size: 137.72 KB |
| Page Load Time: 0.465843 Seconds |
| Website IP Address: 35.212.110.16 |
coyatherapeutics.com Similar Website
| Multiple Sclerosis Association of America My Health Insurance Guide - Multiple Sclerosis Association |
| Home - 2023 Targeted Therapies of Lung Cancer Meeting |
| Ayurvedic Doctor - Ask Dr Charak for Panchkarma Therapies, Health Diseases & Conditions |
| Houston News, Sports, Business, and Entertainment - The Houston Chronicle at Chron.com - Houston Chr |
| Covidien Products | Medtronic Minimally Invasive Therapies |
| SharePoint Houston Consulting Company | Houston Sharepoint Consulting Solution | Houston Sharepoint |
| Solarcentury - International solar PV company | developing worldwide |
| Summing Based On Multiple Conditions |
| NCBiotech Company Directory | We make connections that create biotech jobs. |
| LASIK Houston Texas | Cataract Surgery Houston TX | Houston Eye |
| Houston Public Works Document Repository | City of Houston - Houston Public Works |
| Softhover: Java Software Company Specialized in enterprise application developing, data mining, deve |
| Neuropathix, Inc. – A Phyto-Medical Company | Developing Pharmaceuticals to Protect the Brain |
| GC biotech webshop – GC biotech – Translating Life Sciences Into |
coyatherapeutics.com PopUrls
| Houston biotech company developing multiple Treg-based ... https://coyatherapeutics.com/ |
| Press Releases & News from Houston Biotech ... https://coyatherapeutics.com/news/ |
| Contact https://coyatherapeutics.com/contact/ |
| Houston Biotech Company Targeting Treg Dysfunction https://coyatherapeutics.com/pipeline/ |
| Privacy Policy - Coya Therapeutics https://coyatherapeutics.com/privacy-policy/ |
| Clinical-Stage Biotech Developing Treg-based Therapies https://coyatherapeutics.com/about-us/ |
| News Archives https://coyatherapeutics.com/category/news/ |
| Resources on neurodegenerative & autoimmune diseases https://coyatherapeutics.com/patient-resources/ |
| Multi-modality Treg Enhancing Therapies https://coyatherapeutics.com/science-and-technology/ |
| A Serendipitous Moment https://coyatherapeutics.com/a-serendipitous-moment/ |
coyatherapeutics.com DNS
| A coyatherapeutics.com. 600 IN A 35.212.110.16 |
| MX coyatherapeutics.com. 21600 IN MX 50 alt4.aspmx.l.google.com. |
| NS coyatherapeutics.com. 3600 IN NS ns49.domaincontrol.com. |
| TXT coyatherapeutics.com. 1800 IN TXT v=spf1 ip4:209.85.220.41 ip4:205.201.128.0/20 ip4:198.2.128.0/18 ip4:148.105.0.0/16 include:_spf.google.com ~all |
| SOA coyatherapeutics.com. 3600 IN SOA ns49.domaincontrol.com. dns.jomax.net. 2023071308 28800 7200 604800 600 |
coyatherapeutics.com Httpheader
| Server: nginx |
| Date: Mon, 13 May 2024 21:12:24 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-XSS-Protection: 1; mode=block |
| Link: https://coyatherapeutics.com/wp-json/; rel="https://api.w.org/", https://coyatherapeutics.com/wp-json/wp/v2/pages/493; rel="alternate"; type="application/json", https://coyatherapeutics.com/; rel=shortlink |
| X-Httpd-Modphp: 1 |
| Host-Header: 8441280b0c35cbc1147f8ba998a563a7 |
| X-Proxy-Cache: HIT |
coyatherapeutics.com Meta Info
| charset="utf-8"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
| content="Houston-based clinical-stage company that develops multiple Treg-modulating therapies for neurodegenerative, autoimmune, and metabolic diseases." name="description" |
| content="en_US" property="og:locale"/ |
| content="website" property="og:type"/ |
| content="Houston biotech company developing multiple Treg-based therapies" property="og:title"/ |
| content="Houston-based clinical-stage company that develops multiple Treg-modulating therapies for neurodegenerative, autoimmune, and metabolic diseases." property="og:description"/ |
| content="https://coyatherapeutics.com/" property="og:url"/ |
| content="Coya Therapeutics" property="og:site_name"/ |
| content="2024-04-22T15:22:01+00:00" property="article:modified_time"/ |
| content="summary_large_image" name="twitter:card"/ |
| content="@CoyaTx" name="twitter:site"/ |
| content="Elementor 3.21.5; features: e_optimized_assets_loading, e_optimized_css_loading, additional_custom_breakpoints; settings: css_print_method-external, google_font-enabled, font_display-auto" name="generator"/ |
| content="https://coyatherapeutics.com/wp-content/uploads/2022/09/Coya-Mark-300x300.png" name="msapplication-TileImage"/ |
coyatherapeutics.com Ip Information
| Ip Country: United States |
| City Name: Washington |
| Latitude: 38.894 |
| Longitude: -77.0365 |
coyatherapeutics.com Html To Plain Text
HomeScience & Technology Pipeline Investor Relations Resources Patient Resources Contact Unleashing the Power of Tregs Multiple Treg therapeutic modalities addressing neurodegenerative, autoimmune, and metabolic diseases Learn MOre We are a clinical-stage company focused on developing our multi-modality Treg therapies for neurodegenerative , autoimmune , and metabolic diseases . Strong proof of concept data in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Treg Enhancing Biologics: Treg Enhancing Biologics: COYA 302 COYA 301 Allogeneic Treg Derived Exosomes: COYA 201 Autologous Treg Cell Therapy: COYA 101 Our Science Video News Keep up-to-date with the latest news about Coya Therapeutics. Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results May 09, 2024 HOUSTON(BUSINESS WIRE) Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya” or the Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function,... Read More Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium Apr 26, 2024 HOUSTON(BUSINESS WIRE) Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya” or the Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function,... Read More Coya Therapeutics to Participate in the Mizuho Neuroscience Summit Apr 22, 2024 HOUSTON(BUSINESS WIRE) Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya” or the Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function,... Read More Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit Apr 18, 2024 HOUSTON(BUSINESS WIRE) Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya” or the Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function,... Read More Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium Apr 08, 2024 Dr. Appel previously presented 4-HNE biomarker data in March 2024 at the Society of Neuroimmune Pharmacology Conference showing high correlation (91.7% sensitivity and 71.1% specificity) Read More Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results Mar 19, 2024 HOUSTON(BUSINESS WIRE) Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya” or the Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function... Read More More News We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. LinksScience & Technology Pipeline Investor Relations Resources Patient ResourcesScience & Technology Pipeline Investor Relations Resources Patient Resources follow us Linkedin Youtube Twitter Contact Us 5850 San Felipe St., Suite 500 Houston, TX 77057 USA +1 800-587-8170 Contact Us © 2024 Coya Therapeutics, Inc. All rights reserved. Privacy Policy Terms & Conditions Biotech Website...
coyatherapeutics.com Whois
Domain Name: COYATHERAPEUTICS.COM Registry Domain ID: 2567493011_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-01-12T17:20:01Z Creation Date: 2020-10-22T13:42:22Z Registry Expiry Date: 2027-10-22T13:42:22Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS49.DOMAINCONTROL.COM Name Server: NS50.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:23:07Z <<<